Menu
GeneBe

rs4540995

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_013382.7(POMT2):c.1654-6A>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.104 in 1,614,048 control chromosomes in the GnomAD database, including 10,268 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1827 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8441 hom. )

Consequence

POMT2
NM_013382.7 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.0001492
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 0.567
Variant links:
Genes affected
POMT2 (HGNC:19743): (protein O-mannosyltransferase 2) The protein encoded by this gene is an O-mannosyltransferase that requires interaction with the product of the POMT1 gene for enzymatic function. The encoded protein is found in the membrane of the endoplasmic reticulum. Defects in this gene are a cause of Walker-Warburg syndrome (WWS).[provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 14-77280469-T-C is Benign according to our data. Variant chr14-77280469-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 95537.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-77280469-T-C is described in Lovd as [Benign]. Variant chr14-77280469-T-C is described in Lovd as [Likely_pathogenic].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.228 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
POMT2NM_013382.7 linkuse as main transcriptc.1654-6A>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000261534.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
POMT2ENST00000261534.9 linkuse as main transcriptc.1654-6A>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_013382.7 P1Q9UKY4-1

Frequencies

GnomAD3 genomes
AF:
0.140
AC:
21260
AN:
152088
Hom.:
1821
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.232
Gnomad AMI
AF:
0.0724
Gnomad AMR
AF:
0.0931
Gnomad ASJ
AF:
0.0910
Gnomad EAS
AF:
0.214
Gnomad SAS
AF:
0.0556
Gnomad FIN
AF:
0.108
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.104
Gnomad OTH
AF:
0.124
GnomAD3 exomes
AF:
0.109
AC:
27303
AN:
251418
Hom.:
1919
AF XY:
0.104
AC XY:
14187
AN XY:
135884
show subpopulations
Gnomad AFR exome
AF:
0.241
Gnomad AMR exome
AF:
0.0614
Gnomad ASJ exome
AF:
0.0934
Gnomad EAS exome
AF:
0.225
Gnomad SAS exome
AF:
0.0513
Gnomad FIN exome
AF:
0.108
Gnomad NFE exome
AF:
0.103
Gnomad OTH exome
AF:
0.101
GnomAD4 exome
AF:
0.100
AC:
146541
AN:
1461842
Hom.:
8441
Cov.:
38
AF XY:
0.0984
AC XY:
71594
AN XY:
727222
show subpopulations
Gnomad4 AFR exome
AF:
0.243
Gnomad4 AMR exome
AF:
0.0638
Gnomad4 ASJ exome
AF:
0.0974
Gnomad4 EAS exome
AF:
0.230
Gnomad4 SAS exome
AF:
0.0520
Gnomad4 FIN exome
AF:
0.104
Gnomad4 NFE exome
AF:
0.0962
Gnomad4 OTH exome
AF:
0.105
GnomAD4 genome
AF:
0.140
AC:
21288
AN:
152206
Hom.:
1827
Cov.:
32
AF XY:
0.138
AC XY:
10296
AN XY:
74410
show subpopulations
Gnomad4 AFR
AF:
0.232
Gnomad4 AMR
AF:
0.0928
Gnomad4 ASJ
AF:
0.0910
Gnomad4 EAS
AF:
0.214
Gnomad4 SAS
AF:
0.0559
Gnomad4 FIN
AF:
0.108
Gnomad4 NFE
AF:
0.104
Gnomad4 OTH
AF:
0.123
Alfa
AF:
0.106
Hom.:
1626
Bravo
AF:
0.144
Asia WGS
AF:
0.110
AC:
385
AN:
3478
EpiCase
AF:
0.102
EpiControl
AF:
0.107

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 26, 2014c.1654-6A>G in intron 15 of POMT2: This variant is not expected to have clinical significance because it has been identified in 23% (1034/4406) of African Ameri can chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington. edu/EVS/; dbSNP rs4540995). -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 18, 2012- -
Autosomal recessive limb-girdle muscular dystrophy type 2N Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 01, 2017- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;C3150416:Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;C3150418:Autosomal recessive limb-girdle muscular dystrophy type 2N Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
Cadd
Benign
7.0
Dann
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00015
dbscSNV1_RF
Benign
0.028
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4540995; hg19: chr14-77746812; COSMIC: COSV55069509; COSMIC: COSV55069509; API